glp 1 agonist muscle loss Do GLP-1 drugs shrink your muscles? New study explains the risks and what to do The future of weight loss?

For patients with chronic kidney disease, heart failure, or established atherosclerotic cardiovascular disease, substituting a sodium-glucose cotransporter 2 (SGLT2) inhibitor may be preferred

Nicotinamide adenine dinucleotide (NAD+) is a critical coenzyme found in every cell of your body, and its involved in hundreds of metabolic processes

Future studies should aim to elucidate the mechanisms underlying these contradictory observations and identify the specific conditions under which GLP-1RAs might exert detrimental effects on the CNS

doi:10.1080/09637486.2023.2284647 Simopoulos AP

Optimizing Timing Around Exercise Exercise creates controlled tissue damage that triggers repair processes